LFB
Prescription Drugs · Biologics & Biosimilars

LFB: Risk & public record

LFB: 31 research papers in five years.

Data updated Nov 20, 2026 · Back to the company report

A real, active employer with honest postings.

Legal entity active
Yes
Postings are real
Alion truth index: A
91/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Domain and mail securitygroupe-lfb.com · Nov 16, 2026
Spoofed mail (DMARC)
No DMARC record · dns.google ↗
Missing
Who may send its mail (SPF)
No SPF record · dns.google ↗
Missing
HTTPS certificate
Valid certificate · SSL Corporation · crt.sh ↗
Good
HTTPS enforced (HSTS)
Good
Security contact (security.txt)
No security.txt · groupe-lfb.com ↗
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy · dns.google ↗
Weak
Signed DNS (DNSSEC)
Not signed · dnsviz.net ↗
Weak
Certificate issuers (CAA)
Any authority may issue certificates · dns.google ↗
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.

Public record

LFB: 31 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
31papers in five years
13kcitations
Hemophilia Treatment and Research
Medicine
96 papers
Monoclonal and Polyclonal Antibodies Research
Immunology and Microbiology
95 papers
Platelet Disorders and Treatments
Medicine
85 papers
Blood transfusion and management
Medicine
55 papers
Blood Coagulation and Thrombosis Mechanisms
Medicine
51 papers
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.